urological tumours

Association between Geriatric Nutritional Risk Index and survival outcomes in patients with urological cancers: an updated meta-analysis
I-Wen Chen, Jui-Hung Hsu, Jing-Cyuan Huang, Wei-Cheng Liu, Jheng-Yan Wu, Kuei-Fen Wang, Kuo-Chuan Hung

BMJ Open Feb 2025, 15 (2) e091639; DOI: 10.1136/bmjopen-2024-091639
Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study
Marcus Cumberbatch, Bernard North, Roseann Kealy, Samuel Smith, Rachel Hubbard, Steven Kennish, Selina Bhattrai, William Cross, Rohit Chahal, Richard Bryant, Alastair D Lamb, Mohantha Dooldeniya, Simon Faulkner, Peter Sasieni, James Catto

BMJ Open Feb 2025, 15 (2) e096431; DOI: 10.1136/bmjopen-2024-096431
Cost–utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer
Paul Muhler, Dennis Akuamoa-Boateng, Johannes Rosenbrock, Stephanie Stock, Dirk Müller, Axel Heidenreich, Julia Simões Corrêa Galendi

BMJ Open Jan 2025, 15 (1) e088495; DOI: 10.1136/bmjopen-2024-088495
How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
Emmeli Palmstedt, Marianne Månsson, Karin Stinesen Kollberg, Sigrid Carlsson, Mikael Hellström, Jonas Wallström, Jonas Hugosson, Rebecka Arnsrud Godtman

BMJ Open Aug 2024, 14 (8) e083562; DOI: 10.1136/bmjopen-2023-083562
ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol
Michael E Rezaee, Katherine M Mahon, Bruce J Trock, The-Hung Edward Nguyen, Armine K Smith, Noah M Hahn, Sunil H Patel, Max Kates

BMJ Open Jun 2024, 14 (6) e076763; DOI: 10.1136/bmjopen-2023-076763
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study
Soumaya Labidi, Nicholas Meti, Reeta Barua, Mengqi Li, Jamila Riromar, Di Maria Jiang, Nazanin Fallah-Rad, Srikala S Sridhar, Sonia V Del Rincon, Rossanna C Pezo, Cristiano Ferrario, Susanna Cheng, Adrian G Sacher, April A N Rose

BMJ Open Mar 2024, 14 (3) e081480; DOI: 10.1136/bmjopen-2023-081480
Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk
James WF Catto, Bernard North, Megan Goff, Abigail Carter, Michelle Sleeth, Olena Mandrik, Jim Chilcott, Peter Sasieni, Marcus G K Cumberbatch

BMJ Open Sep 2023, 13 (9) e076612; DOI: 10.1136/bmjopen-2023-076612
Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database
Liuxiong Guo, Liang Liu, Yixuan Liu, Tao Yang, Gang Wang, Junjiang Liu, Suwei Li, Jianhui Cai

BMJ Open Mar 2024, 14 (3) e080092; DOI: 10.1136/bmjopen-2023-080092
Beating the empty pelvis syndrome: the PelvEx Collaborative core outcome set study protocol
PelvEx Collaborative

BMJ Open Feb 2024, 14 (2) e076538; DOI: 10.1136/bmjopen-2023-076538
Living systematic review and meta-analysis of the prostate MRI diagnostic test with Prostate Imaging Reporting and Data System (PI-RADS) assessment for the detection of prostate cancer: study protocol
Benedict Oerther, Christine Schmucker, Guido Schwarzer, Ivo Schoots, August Sigle, Christian Gratzke, Fabian Bamberg, Matthias Benndorf

BMJ Open Oct 2022, 12 (10) e066327; DOI: 10.1136/bmjopen-2022-066327

Main menu

urological tumours

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

urological tumours

Pages